Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)
| 16.27 Delayed Data As of Nov 29 |  -0.22 / -1.33%Today’s Change | 5.24 Today|||52-Week Range 18.39 | +140.32% Year-to-Date |
Latest CPRX News | Press Releases
| Corcept (CORT) Up YTD on Robust Korlym Sales, Pipeline Advances Nov 16 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 16.49 |
| Today’s open | 16.60 |
| Day’s range | 16.20 - 16.92 |
| Volume | 97,429 |
| Average volume (3 months) | 3,065,067 |
| Market cap | $1.8B |
Data as of 3:59pm ET, 11/29/2022
Growth & Valuation
| Earnings growth (last year) | -47.28% |
| Earnings growth (this year) | +96.22% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +18.27% |
| P/E ratio | 26.7 |
| Price/Sales | 5.18 |
| Price/Book | 8.46 |
Competitors
Data as of 4:00pm ET, 11/29/2022
Financials
| Next reporting date | March 15, 2023 |
| EPS forecast (this quarter) | $0.20 |
| Annual revenue (last year) | $140.8M |
| Annual profit (last year) | $39.5M |
| Net profit margin | 28.03% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Coral Gables, Florida |
Forecasts
